{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:06Z","timestamp":1790050686398,"version":"4.0.1"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T00:00:00Z","timestamp":1318377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe chronic active Epstein\u2013Barr virus infection (CAEBV) in T or NK cells is a rare complication of latent EBV infection. CAEBV associated T\u2010cell lymphoproliferative disease (LPD) consists of polyclonal lesions as well as aggressive lymphomas. Here, we report such a patient. In addition, we show that this primary CAEBV associated T\u2010cell lymphoma expresses CD70 and is sensitive to killing by CD70\u2010specific T cells, identifying CD70 as a potential immunotherapeutic target for CAEBV\u2010associated T\u2010cell lymphoma. Pediatr Blood Cancer 2012;59:758\u2013761. \u00a9 2011 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/pbc.23352","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T14:20:31Z","timestamp":1318429231000},"page":"758-761","source":"Crossref","is-referenced-by-count":7,"title":["Aggressive peripheral CD70\u2010positive t\u2010cell lymphoma associated with severe chronic active EBV infection"],"prefix":"10.1002","volume":"59","author":[{"given":"Donald R.","family":"Shaffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl C.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona M.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,12]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/367988"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp064"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.280"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1998.tb03864.x"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-091280"},{"key":"e_1_2_4_8_2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.4049\/jimmunol.152.4.1762","article-title":"Characterization of the human CD27 ligand, a novel member of the TNF gene family","volume":"152","author":"Hintzen RQ","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-278218"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2008.02213.x"},{"key":"e_1_2_4_11_2","first-page":"278","volume-title":"WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues","author":"Quintanilla\u2010Martinez L","year":"2008"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.122"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/587671"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02488-0"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-316745"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703796"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.01.020"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-034017"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02013-07"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0253"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.23352","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.23352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:13:08Z","timestamp":1696896788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.23352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,12]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1002\/pbc.23352"],"URL":"https:\/\/doi.org\/10.1002\/pbc.23352","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,12]]}}}